A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists Apr, 2015 | Pubmed ID: 25809373